The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Galera Therapeutics, Inc(NASDAQ:GRTX) 
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimet...
Website: http://www.galeratx.com
Full Time Employees: 32
CEO: J. Mel Sorensen
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Galera Therapeutics Days Payable Outstanding ttm (DPO)
Galera Therapeutics Op Cashflow Per Share ttm
Galera Therapeutics Free Cashflow Per Share ttm
Galera Therapeutics Cash Per Share ttm
Galera Therapeutics (GAAP) P/E ratio ttm
Galera Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.